First Trust Nasdaq Pharmaceuticals ETF (FTXH)
| Assets | $1.14B |
| Expense Ratio | 0.60% |
| PE Ratio | 30.96 |
| Forward PE | 17.10 |
| Shares Out | 26.75M |
| Dividend | $0.29 (0.67%) |
| Ex-Dividend Date | Sep 24, 2026 |
| Payout Frequency | Quarterly |
| Payout Ratio | 20.76% |
| Volume | 131,722 |
| Open | 42.78 |
| Previous Close | 43.12 |
| Day's Range | 42.78 - 43.51 |
| 52-Week Low | 29.40 |
| 52-Week High | 43.52 |
| Beta | 0.46 |
| Holdings | 51 |
| Inception Date | Sep 20, 2016 |
About FTXH
Fund Home PageThe First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is issued by First Trust.
Top 10 Holdings
54.87% of assets| Name | Symbol | Weight |
|---|---|---|
| AbbVie Inc. | ABBV | 7.69% |
| Eli Lilly and Company | LLY | 7.63% |
| Pfizer Inc. | PFE | 7.21% |
| Johnson & Johnson | JNJ | 6.96% |
| Merck & Co., Inc. | MRK | 6.61% |
| Biogen Inc. | BIIB | 4.01% |
| Viatris Inc. | VTRS | 3.90% |
| Gilead Sciences, Inc. | GILD | 3.74% |
| Amgen Inc. | AMGN | 3.59% |
| United Therapeutics Corporation | UTHR | 3.54% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 24, 2026 | $0.0113 | Sep 30, 2026 |
| Jun 25, 2026 | $0.092 | Jun 30, 2026 |
| Mar 26, 2026 | $0.0573 | Mar 31, 2026 |
| Dec 12, 2025 | $0.1294 | Dec 31, 2025 |
| Sep 25, 2025 | $0.1453 | Sep 30, 2025 |
| Jun 26, 2025 | $0.0892 | Jun 30, 2025 |
Performance
FTXH had a total return of 47.32% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.05%.
News
Trump to announce discount drug pricing expansion, White House official says
U.S. President Donald Trump will announce a dramatic expansion of TrumpRx.gov, a government-backed website offering discounted prescription drugs under his administration's pricing deal, on Monday, ...
Could pressure to make money faster kill the next lifesaving pill?
When activist investors take a stake in a pharmaceutical company, markets often cheer. The expectation is leaner operations, sharper strategy and higher stock prices.
Trump announces 100% tariffs on pharmaceutical drugs, beginning October 1
President Donald Trump said Thursday that he will put import taxes of 100% on pharmaceutical drugs, 50% on kitchen cabinets and bathroom vanities, 30% on upholstered furniture and 25% on heavy trucks ...
ETF Spotlight: Pharmaceuticals driven higher by Pfizer
CNBC'S Morgan Brennan takes a look at pharmaceutical as Pfizer's positive vaccine news has led the sector higher.